Micheline C. Sarbach , Stephan Rüegg , Samuel S. Allemann , Isabelle Arnet
{"title":"Personalized adherence interventions using medication adherence technologies in polypharmacy management in epilepsy: An interprofessional case report","authors":"Micheline C. Sarbach , Stephan Rüegg , Samuel S. Allemann , Isabelle Arnet","doi":"10.1016/j.ebr.2025.100767","DOIUrl":"10.1016/j.ebr.2025.100767","url":null,"abstract":"<div><div>We describe a male patient with symptomatic multifocal epilepsy struggling with medication adherence. He accepted escalating adherence interventions with conventional dosing aids such as pillboxes and medication adherence technologies (MATech) including a smart medication dispensing and adherence device (SMAD). Adherence metrics and drug levels were continuously monitored by electronic monitoring (EM) and therapeutic drug monitoring (TDM). Initially, adherence metrics with pre-filled punch cards supplied by a community pharmacy showed 64% taking adherence, 63% timing adherence, and 47% correctly dosed days, including a five-day medication holiday. Adherence improved with a pharmacy-filled SMAD, reaching 93% taking adherence, 90% timing adherence, 86% correctly dosed days, and no medication holiday. No epileptic seizures were noticed during periods with EM. The patient was satisfied with the SMAD while struggling with other adherence tools. Adherence tended to decrease once adherence reminders were removed. In conclusion, we emphasize the importance of personalized adherence strategies and shared decision-making. This case highlights the positive impact of an interprofessional adherence improvement program, integrating efforts from researchers, neurologists, and community pharmacists.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"30 ","pages":"Article 100767"},"PeriodicalIF":1.8,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143881715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparing the risk of subsequent ischemic stroke and mortality in patients with epilepsy and patients with ischemic stroke","authors":"Po-Yu Lin , Sheng-Hsiang Lin , Pi-Shan Sung","doi":"10.1016/j.ebr.2025.100766","DOIUrl":"10.1016/j.ebr.2025.100766","url":null,"abstract":"<div><div>Patients with stroke or epilepsy face an elevated risk of subsequent strokes. This nationwide retrospective cohort study analyzed data from Taiwan’s National Health Insurance Research Database (2012–2020) to compare the risk of future ischemic stroke or transient ischemic attack (IS/TIA) among patients with epilepsy and those with prior IS/TIA. Patients were categorized into four groups: epilepsy with subsequent IS/TIA (E/S), epilepsy without IS/TIA (E), IS/TIA without epilepsy (S), and neither condition (C). Incidence rates and adjusted hazard ratios for IS/TIA and mortality were assessed across groups, which included 5,606, 11,212, 11,212, and 56,060 patients. The corresponding incidence rates of subsequent IS/TIA were 0.67, 0.03, 0.41, and 0.01 per 100 person-years in the E/S, E, S, and C groups, respectively. Compared to the S group, the E/S group had a higher adjusted hazard ratio for IS/TIA (aHR 1.68, 95% CI: 1.30–2.17), whereas the E group had a significantly lower adjusted hazard ratio (aHR 0.08, 95% CI: 0.04–0.14). Mortality risk was significantly elevated in both the E/S group (aHR 1.90, 95% CI: 1.75–2.05) and the E group (aHR 1.21, 95% CI: 1.12–1.30), compared to the S group. These findings suggest that epilepsy increases the risk of subsequent IS/TIA, though to a lesser extent than prior IS/TIA. They underscore the importance of condition-specific prevention strategies and the need for further research into the mechanisms linking epilepsy and stroke risk.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"30 ","pages":"Article 100766"},"PeriodicalIF":1.8,"publicationDate":"2025-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143815807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vijaya Lakshmi Valaparla , Aabishkar Bhattarai , Patrick J. Karas , Diosely C. Silveira
{"title":"Coexistence of Charles Bonnet Syndrome and occipital epilepsy: A diagnostic challenge","authors":"Vijaya Lakshmi Valaparla , Aabishkar Bhattarai , Patrick J. Karas , Diosely C. Silveira","doi":"10.1016/j.ebr.2025.100764","DOIUrl":"10.1016/j.ebr.2025.100764","url":null,"abstract":"<div><div>Charles Bonnet Syndrome (CBS) is a condition characterized by complex visual hallucinations in individuals with visual impairment. We present the case of a patient with bilateral optic atrophy secondary to obstructive hydrocephalus caused by a pineal parenchymal tumor of intermediate differentiation (PPTID) who experienced formed visual hallucinations consistent with CBS. Following a right occipital craniotomy for occipital transtentorial approach and tumor resection, she developed elementary visual hallucinations. A thorough clinical history and systematic diagnostic evaluation led to the identification of coexisting right occipital epilepsy. This case highlights an intriguing overlap of two positive visual phenomena with distinct pathophysiological mechanisms.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"30 ","pages":"Article 100764"},"PeriodicalIF":1.8,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143903624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jie Fu , Qinrui Li , Genfu Zhang , Zhixian Yang , Jiong Qin
{"title":"Neuropsychiatric disorders in Chinese pediatric tuberous sclerosis complex patients associated with drug-resistant epilepsy: A TAND checklist-based survey","authors":"Jie Fu , Qinrui Li , Genfu Zhang , Zhixian Yang , Jiong Qin","doi":"10.1016/j.ebr.2025.100765","DOIUrl":"10.1016/j.ebr.2025.100765","url":null,"abstract":"<div><div>Tuberous sclerosis complex (TSC) is an autosomal-dominant genetic disorder frequently accompanied by neuropsychiatric disorders, especially in patients who have drug-resistant epilepsy (DRE). This study aimed to evaluate the distribution of neuropsychiatric disorders in Chinese children with TSC-related epilepsy using the TAND (Tuberous Sclerosis Complex Associated Neuropsychiatric Disorders) checklist, comparing those with DRE to those achieving seizure freedom. A total of 47 children, aged 6 to 18 years, diagnosed with TSC at Peking University People’s Hospital, participated in this cross-sectional study.<!--> <!-->All participants met the latest diagnostic criteria for TSC. Based on the definition of drug-resistant epilepsy, participants were categorized into DRE group and seizure-free group. Neurodevelopmental disorders were evaluated using the TAND checklist. The study found that 66 % of participants exhibited varying degrees of intellectual disability, with the DRE group demonstrating significantly poorer performance in intelligence, behavior, neuropsychological, and learning skills compared to the seizure-free group. The DRE group also had higher rates of attention-deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), alongside greater impairments in psychosocial functioning. This study indicates that DRE is strongly associated with neuropsychiatric development in children with TSC, but also that all children with TSC are at increased risk of TAND. Our findings highlight the importance of regular assessment and intervention to support TAND and improve quality of life in this vulnerable group.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"30 ","pages":"Article 100765"},"PeriodicalIF":1.8,"publicationDate":"2025-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143783529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Tramadol use and risk of seizure: A report of two cases and a review of recent literature","authors":"Emma Dolan , Norman Delanty","doi":"10.1016/j.ebr.2025.100763","DOIUrl":"10.1016/j.ebr.2025.100763","url":null,"abstract":"<div><div>Tramadol is a common pain medication used in practice across numerous specialties. Increased incidence of tramadol abuse and overdose in recent decades has led to it being classified as a controlled drug in several countries. Tramadol appears to be an increasingly popular drug of abuse, possibly related to ease of access to it on prescription, and its potential euphoric effects.</div><div>We identified two cases of seizures directly related to tramadol exposure. We then reviewed recent literature on tramadol and its adverse effects, particularly looking at its effect on seizure risk and the incidence of seizures. We found that there were scarce recent studies on the relationship between tramadol and seizure risk. Of studies found, many were carried out in animal models. Tramadol-induced seizures were studied in humans more commonly in the context of overdose, and studies involving humans tended to have small patient cohorts and suggested further study in the area.</div><div>We suggest that tramadol may be useful as part of multi-modal analgesia in moderate to severe pain in specific contexts, but that greater awareness of its potential adverse effects, and particularly its potential to lower seizure threshold, is warranted. We feel that more readily available information specifically about tramadol’s effects on seizure threshold may be of interest to colleagues from any specialty prescribing opioid analgesia on a regular basis, but that colleagues treating patients with seizure disorders should be particularly aware of these potential adverse effects.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"30 ","pages":"Article 100763"},"PeriodicalIF":1.8,"publicationDate":"2025-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143769032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Franziska van den Bongard , Catharina Petersen , Claus Reinsberger
{"title":"Safety and feasibility of exhaustive exercise testing for people with epilepsy","authors":"Franziska van den Bongard , Catharina Petersen , Claus Reinsberger","doi":"10.1016/j.ebr.2025.100762","DOIUrl":"10.1016/j.ebr.2025.100762","url":null,"abstract":"<div><div>People with epilepsy (PWE) are encouraged to participate in exercise and be physically active, but some PWE may report exercise-associated seizures (EAS). However, there is a lack of objective tools to inform individual recommendations for physical activity and exercise participation in PWE. This study investigated the feasibility and safety of exhaustive exercise testing in PWE. 29 patients underwent an objectively and subjectively exhaustive exercise test on a bicycle ergometer and resting state EEG was obtained before and after exercise. One patient with a history of EAS experienced a seizure immediately after exercising. In patients without EAS, an asymptomatic subclinical electrographic seizure was observed in one patient, and two patients revealed interictal epileptiform discharges only after exercise. All EEG changes occurred in the setting of non-REM sleep, while the respective pre-exercise EEG recordings revealed less sleep. No seizures or significant EEG changes after exercise were observed in any other patient. EEG investigations before and after exhaustive exercise were feasible in PWE, but safety protocols need to be established, especially in patients with EAS. Investigation of a higher number of PWE with and without EAS with repeat exercise-associated EEG may provide information about the clinical utility of exercise-associated EEGs when counseling PWE.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"30 ","pages":"Article 100762"},"PeriodicalIF":1.8,"publicationDate":"2025-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143725271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Daniel Uher , Gerhard S. Drenthen , Christianne M. Hoeberigs , Rick H.G.J. van Lanen , Albert J. Colon , Roy A.M. Haast , Vivianne H.J.M. van Kranen-Mastenbroek , Guido Widman , Paul A.M. Hofman , Louis G. Wagner , Jan C. Beckervordersandforth , Jacobus F.A. Jansen , Olaf E.M.G. Schijns , Walter H. Backes , on behalf of the ACE study group
{"title":"The role of ultra-high field MRI and image processing in the presurgical workup in MRI-negative focal epilepsy: A validated 7T MRI case study","authors":"Daniel Uher , Gerhard S. Drenthen , Christianne M. Hoeberigs , Rick H.G.J. van Lanen , Albert J. Colon , Roy A.M. Haast , Vivianne H.J.M. van Kranen-Mastenbroek , Guido Widman , Paul A.M. Hofman , Louis G. Wagner , Jan C. Beckervordersandforth , Jacobus F.A. Jansen , Olaf E.M.G. Schijns , Walter H. Backes , on behalf of the ACE study group","doi":"10.1016/j.ebr.2025.100761","DOIUrl":"10.1016/j.ebr.2025.100761","url":null,"abstract":"<div><div>This case study demonstrates the value of combined 7 T structural and functional MRI in the presurgical workup of a 24-year-old male with drug-resistant focal epilepsy who was initially considered MRI-negative on clinical 3 T MRI. The patient underwent extensive presurgical workup with 7 T MRI, magnetoencephalography, stereo-electroencephalography, and resection of the suspected right frontal epileptogenic zone. Histopathology showed focal cortical dysplasia (FCD) type IIb. The patient remained 11 months after surgery seizure-free. Retrospective analysis revealed that both structural and functional 7 T MRI showed abnormalities within the resected area. Morphometric Analysis Program (MAP18) detected abnormalities on both 3 T and 7 T images. However, abnormalities were more conspicuous on 7 T. Resting-state functional MRI metrics, particularly regional homogeneity and fractional amplitude of low-frequency fluctuations, demonstrated significantly increased values in both a MAP18-defined region of interest and the entire resected area compared to a healthy control group (p < 0.05). However, extensive unspecific abnormalities were also observed outside the resected region, highlighting the importance of a multimodal approach. This case study illustrates that advanced image processing of ultra-high field structural and resting-state functional MRI scans may enhance the detection of subtle epileptogenic lesions in presurgical evaluation, potentially improving post-operative seizure outcome and associated quality of life.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"30 ","pages":"Article 100761"},"PeriodicalIF":1.8,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143644703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Heidi M. Munger Clary , Gaston Baslet , Gerardo Maria de Araujo Filho , David Dunn , Alexis Tarrada , Coraline Hingray , Andres M. Kanner
{"title":"Medication reference tables for neurologists: A focus on psychotropic medications in epilepsy","authors":"Heidi M. Munger Clary , Gaston Baslet , Gerardo Maria de Araujo Filho , David Dunn , Alexis Tarrada , Coraline Hingray , Andres M. Kanner","doi":"10.1016/j.ebr.2025.100760","DOIUrl":"10.1016/j.ebr.2025.100760","url":null,"abstract":"<div><div>Many psychotropic medications are prescribed to people with epilepsy by neurologists and other non-neurology providers. This article presents summary tables with information on specific psychotropic drug classes (antidepressants, stimulant medications, and antipsychotic medications) including initiation schedules, dosing and indication. Given the overall paucity of epilepsy specific data available, the information is based primarily on regulatory approvals or other general population data, along with unique considerations for epilepsy such as interactions with antiseizure medications. While information is presented across the age span for antidepressants and stimulants, information on antipsychotic medications is focused on the most commonly prescribed medications for adults with psychotic episodes or acutely agitated states. Summary information on psychiatric and cognitive side effects of antiseizure medications and psychotropic benefits of antiseizure medications are also presented. This article is intended to provide a handy reference to neurologists involved in managing mental health in a clinical setting or caring for patients already receiving psychotropic medications for mental health comorbidities. This article provides an overview of a more comprehensive list of psychotropic medications than the case-based articles of the special issue and is intended to supplement the focused and practical information presented in the other articles.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"30 ","pages":"Article 100760"},"PeriodicalIF":1.8,"publicationDate":"2025-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143912876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Natascha C. da Fonseca , Afsaneh Talai , Daniel Veltkamp , Fabricio S. Feltrin , Dallas Armstrong , Angela Price , Joseph A. Maldjian , Elizabeth M. Davenport
{"title":"Beamforming of ictal MEG aiding subtle focal cortical dysplasia localization","authors":"Natascha C. da Fonseca , Afsaneh Talai , Daniel Veltkamp , Fabricio S. Feltrin , Dallas Armstrong , Angela Price , Joseph A. Maldjian , Elizabeth M. Davenport","doi":"10.1016/j.ebr.2025.100759","DOIUrl":"10.1016/j.ebr.2025.100759","url":null,"abstract":"<div><div>A case is presented of a 17-year-old right-handed male with drug-resistant epilepsy (DRE), initially presenting with non-lesional MRI findings, where ictal MEG beamforming successfully localized a subtle Focal Cortical Dysplasia (FCD). His seizure onset began at age 13, with episodes evolving into bilateral tonic-clonic seizures. Despite various medication trials and normal initial electroencephalograms, his seizures escalated in frequency and severity by age 16. Subsequent diagnostics were unable to reveal definitive lesions, including a high-resolution MRI and various functional imaging techniques. MEG was performed, capturing two electroclinical seizures but without interictal epileptiform discharges. Frequency-based beamforming analysis localized the seizure onset to the right anterior precuneus and superior parietal lobule. This result prompted a re-evaluation of the same MRI images, revealing subtle cortical abnormalities and pinpointing an FCD. Subsequent stereoelectroencephalography confirmed these findings, and the patient underwent successful Laser Interstitial Thermal Therapy, resulting in seizure freedom. This case highlights the utility of frequency-based ictal MEG beamforming in identifying epileptogenic zones and its potential as a powerful tool in the presurgical assessment of DRE patients and non-invasive identification of subtle FCD, especially when traditional methods are unable to localize.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"30 ","pages":"Article 100759"},"PeriodicalIF":1.8,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143644791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Haneieh Honarmand , Mortaza Bonyadi , Mohammad Barzegar
{"title":"Genetic insights into progressive myoclonic epilepsies: A case study of KCTD7 mutation in an Iranian-Azeri-Turkish family","authors":"Haneieh Honarmand , Mortaza Bonyadi , Mohammad Barzegar","doi":"10.1016/j.ebr.2025.100757","DOIUrl":"10.1016/j.ebr.2025.100757","url":null,"abstract":"<div><div>Progressive Myoclonic Epilepsies (PMEs) are a rare and heterogeneous group of epileptic disorders often with progressive neurologic deterioration. The intensity of the clinical features varies depending on the underlying genetic etiology. This study aims to identify the genetic mutation associated with PME in a family belonging to the Iranian-Azeri-Turkish ethnic population. A 5-year-old boy and his 8-year-old sister, presenting with PME-related electroclinical features such as myoclonic seizures and progressive cognitive and motor decline, underwent comprehensive clinical evaluations, including pedigree analysis, laboratory tests, and EEG assessments, followed by Whole-Exome Sequencing (WES) to identify potential disease-causing mutations. We identified a novel homozygous mutation (c.14C > T) in the <em>KCTD7</em> gene in both siblings, confirmed through Sanger sequencing. This mutation was not observed in a cohort of 430 healthy individuals from the same Iranian-Azeri-Turkish ethnic background, providing strong evidence for its pathogenic role. This finding advances our understanding of the genetic basis and phenotypic diversity of PMEs, but further research is needed to elucidate how <em>KCTD7</em> mutations contribute to epilepsy and neurodegeneration.</div></div>","PeriodicalId":36558,"journal":{"name":"Epilepsy and Behavior Reports","volume":"30 ","pages":"Article 100757"},"PeriodicalIF":1.8,"publicationDate":"2025-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143535103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}